Daniel F. Heitjan

Southern Methodist University — United States

Mathematics · Physical Sciences

70h-index21.3kcitations338works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Statistical Methods in Clinical Trials(49), Statistical Methods and Bayesian Inference(41), Advanced Causal Inference Techniques(38), Statistical Methods and Inference(37), Health Systems, Economic Evaluations, Quality of Life(31)

Publications337 total

Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes
Frontiers in Cardiovascular Medicine·2025· 1 citedOpen Access
777-P: Predictors of Selection of a GLP1RA vs. SGLT2i in People with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Diabetes·2024
Response to comments on ‘sensitivity of estimands in clinical trials with imperfect compliance’
The International Journal of Biostatistics·2024· 1 cited
Comment on “Causal interpretation of the hazard ratio in randomized clinical trials” by Fay and Li
Clinical Trials·2024· 1 cited
Predicting Hospital Readmission in Medicaid Patients With COPD Using Administrative and Claims Data
Respiratory Care·2024· 2 citedOpen Access
Tutorial: Assessing the impact of nonignorable missingness on regression analysis using Index of Local Sensitivity to Nonignorability.
Psychological Methods·2023· 4 citedOpen Access
P‐IS‐3 | Establishing Reference Intervals for Clinical Laboratory Tests: The Role of Blood Centers
Transfusion·2023Open Access
Electronic phenotypes to distinguish clinician attention to high body mass index, hypertension, lipid disorders, fatty liver and diabetes in pediatric primary care: Diagnostic accuracy of electronic phenotypes compared to masked comprehensive chart review
Pediatric Obesity·2023Open Access
Sensitivity of estimands in clinical trials with imperfect compliance
The International Journal of Biostatistics·2023· 2 cited
Supplementary Methods from Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy
2023Open Access
Supplementary Figure Legend from CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb<sup>+</sup> Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2023Open Access
Data from CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb<sup>+</sup> Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2023Open Access
Related Article from Biology, Models, and the Analysis of Tumor Xenograft Experiments
2023Open Access
Data from Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy
2023Open Access
Supplementary Figures from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
2023Open Access
Supplemental Table 1 from CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb<sup>+</sup> Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2023Open Access
Supplementary Figure Legends from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
2023Open Access
Supplementary Figure 1 from Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy
2023Open Access
Related Article from Biology, Models, and the Analysis of Tumor Xenograft Experiments
2023Open Access
Supplementary Figures from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
2023Open Access
page 1 of 17Next →

Frequent Co-authors

Steven Μ. Albelda(5), Peter J. O’Dwyer(5), Judith S. Jacobson(5), Victor R. Grann(5), Alfred I. Neugut(5), Yunyoung C Chang(4), Andrea B. Troxel(4), Kay-See Tan(4), Laura Pontiggia(4), Lisa E. Davis(4), Ravi K. Amaravadi(4), Edward A. Stadtmauer(4), Robert H. Vonderheide(4), Alan J. Moskowitz(3), Richard G. Carroll(3), Carl H. June(3), Shengfu Piao(3), Reshma Rangwala(3), Angela DeMichele(3), David Porter(3)